2004Zhongguo yaolixue tongbaoRequires access

Effect of PQS on the cell immune system of the patients with CPHD

Xu Li

Open publisher page 1 citations

Abstract

Aim To investigate the effect of Panax Quinquefolium Saponin (PQS) on the cell immune system of the patients with Chronic Pulmonary Heart Disease (CPHD) and then to find out the relationship between the immune system and the mechanism of CPHD. Methods The T lymph subgroup and NK (CD3 -/CD16+56 +) cells in patients’ peripheral blood were detected by flow cytometry, and the expression of IL 2, IFNγ mRNA were analyzed by RT PCR. Results CD3 +, CD4 + and CD4/CD8 in patients with CPHD were significantly lower than those in the control, while CD8 + higher ( P 0 01). CD3 +, CD4 +, CD4/CD8 and NK (CD3 -/CD16+56 +) cells in the patients were increased after PQS treated, and CD3 +, CD4 + were significantly different from pre treated ( P 0 05), while CD8 + cells were significantly lower than those in pre treated ( P 0 05). PQS stimulated the expression of IL 2, IFNγ mRNA excreted by T lymph cells. Conclusions The results showed that PQS can improve the cell immune function, especially in patients with CPHD whose immune function are low.

About this research paper

What this paper is about

Aim To investigate the effect of Panax Quinquefolium Saponin (PQS) on the cell immune system of the patients with Chronic Pulmonary Heart Disease (CPHD) and then to find out the relationship between the immune system and the mechanism of CPHD. Methods The T lymph subgroup and NK (CD3 -/CD16+56 +) cells in patients’ peripheral blood were detected by flow cytometry, and the expression of IL 2, IFNγ mRNA were analyzed by RT PCR. Results CD3 +, CD4 + and CD4/CD8 in patients with CPHD were significantly lower than those in the control, while CD8 + higher ( P 0 01). CD3 +, CD4 +, CD4/CD8 and NK (CD3 -/CD16+56 +) cells in the patients were increased after PQS treated, and CD3 +, CD4 + were significantly different from pre treated ( P 0 05), while CD8 + cells were significantly lower than those in pre treated ( P 0 05). PQS stimulated the expression of IL 2, IFNγ mRNA excreted by T lymph cells. Conclusions The results showed that PQS can improve the cell immune function, especially in patients with CPHD whose immune function are low.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Aim To investigate the effect of Panax Quinquefolium Saponin (PQS) on the cell immune system of the patients with Chronic Pulmonary Heart Disease (CPHD) and then to find out the relationship between the immune system and the mechanism of CPHD. Methods The T lymph subgroup and NK (CD3 -/CD16+56 +) cells in patients’ peripheral blood were detected by flow cytometry, and the expression of IL 2, IFNγ mRNA were analyzed by RT PCR. Results CD3 +, CD4 + and CD4/CD8 in patients with CPHD were significantly lower than those in the control, while CD8 + higher ( P 0 01). CD3 +, CD4 +, CD4/CD8 and NK (CD3 -/CD16+56 +) cells in the patients were increased after PQS treated, and CD3 +, CD4 + were significantly different from pre treated ( P 0 05), while CD8 + cells were significantly lower than those in pre treated ( P 0 05). PQS stimulated the expression of IL 2, IFNγ mRNA excreted by T lymph cells. Conclusions The results showed that PQS can improve the cell immune function, especially in patients with CPHD whose immune function are low.

Key concepts: Immune system, CD8, CD3, Flow cytometry, T cell, Immunology, Lymph, CD16

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of PQS on the cell immune system of the patients with CPHD — Research Paper | ScholarLens